Association of and Null Genotypes with Toluene Diisocyanate-Induced Asthma.

Can Respir J

Division of Allergy and Respiratory Medicine, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Republic of Korea.

Published: May 2022

AI Article Synopsis

  • Toluene diisocyanate (TDI) can cause occupational asthma by creating oxidative stress that harms tissues and causes inflammation; researchers investigated the link between specific GST gene genotypes and TDI-induced asthma.
  • The study involved 26 asthmatics who reacted positively to TDI and 27 who did not; findings showed that the GSTM1 null genotype was more prevalent in those with positive TDI responses, suggesting a genetic predisposition to TDI-OA.
  • Results indicated that individuals with certain GST gene variants had lower glutathione transferase levels post-TDI challenge, implying that these genetic markers could be important in diagnosing and assessing risk for TDI-induced occupational asthma.

Article Abstract

Background: Toluene diisocyanate (TDI) causes occupational asthma by generating oxidative stress, leading to tissue injury and inflammation. Glutathione transferases (GSTs) are detoxifying enzymes that eliminate oxidative stress. We examined whether the genotypes of the and genes are associated with TDI-induced occupational asthma (TDI-OA).

Methods: The study population consisted of 26 asthmatics with a positive response to the TDI challenge (TDI-PA) and 27 asthmatics with negative responses (TDI-NA). and null and wild-type genotypes were determined using multiplex PCR. The plasma GSTM1 and GSTT1 protein concentrations were determined using ELISA.

Results: The null genotype was more frequent in the TDI-PA than in the TDI-NA (77.8 . 50.0%, OR = 3.5, =0.03), while the frequency of the null genotype tended to be higher in the TDI-PA than in the TDI-NA (59.3 . 42.3%, OR = 1.98, =0.21). When analyzed together, the / null genotype was more frequent in the TDI-PA than in the TDI-NA (48.2 . 15.3%, OR = 6.5, =0.04). The decline in the FEV in 1 s after TDI challenge was higher with the / null than the wild-type/ null genotypes (24.29% . 7.47%, =0.02). The plasma GSTM1 level was lower with the null than with the wild-type genotypes both before (13.7 . 16.6 ng/mg, =0.04) and after (12.9 . 17.1 ng/mg, =0.007) the TDI challenge, while the GSTT1 level was not changed with either the null or wild-type genotype.

Conclusions: The null genotype, but not alone, may confer susceptibility to TDI-OA. However, the genetic effect of the null genotype may be enhanced synergistically by the null genotype. The genetic effect of was validated in the plasma as the GSTM1 protein level. Therefore, the and genotypes may be useful diagnostic markers for TDI-OA.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856815PMC
http://dx.doi.org/10.1155/2022/7977937DOI Listing

Publication Analysis

Top Keywords

null genotype
24
tdi challenge
12
null wild-type
12
plasma gstm1
12
tdi-pa tdi-na
12
null
11
null genotypes
8
occupational asthma
8
oxidative stress
8
wild-type genotypes
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!